ライフサイエンスコーパス: enteritidis

1 eterminant of LPS that S Typhi shares with S Enteritidis.

2 e development of a SNP typing scheme with S. Enteritidis.

3 ia monocytogenes and Salmonella enterica sv. Enteritidis.

4 ribute to successful egg contamination by S. Enteritidis.

5 th Abs generated against S Typhimurium and S Enteritidis.

6 87/91 is a recently evolved descendent of S. Enteritidis.

7 VA) method for subtyping Salmonella serotype Enteritidis.

8 reaks caused by Salmonella enterica serotype Enteritidis.

9 n of outbreaks caused by Salmonella serotype Enteritidis.

10 with progeny response to S. enterica serovar Enteritidis.

11 t in the transmission of S. enterica serovar Enteritidis.

12 -transferase-LpfA fusion protein of serotype Enteritidis.

13 ge type (PT) reference strains of Salmonella enteritidis.

14 methods for the epidemiological typing of S. enteritidis.

15 ous than the flagella observed on Salmonella enteritidis.

16 he chicken ovaries by invasive strains of S. enteritidis.

17 ied nonpasteurized liquid eggs containing S. enteritidis.

18 rapid, and powerful subtyping method for S. enteritidis.

19 ogenes, Staphylococcus aureus and Salmonella enteritidis.

20 aradox surrounds Salmonella enterica serovar Enteritidis.

21 st OMPs isolated from S. Choleraesuis and S. Enteritidis.

22 sequence type 11 the major ST among serovar Enteritidis.

23 detection and characterization method for S. Enteritidis.

24 of the isolates, 3 of which were Salmonella Enteritidis.

25 Typhimurium and 1608 (15.8%) were Salmonella Enteritidis.

26 d ecological origins of S. enterica serotype Enteritidis.

27 did bacterial lipopolysaccharides Salmonella enteritidis (0.24 nmol/L, 5-fold) greater than Helicobac

28 Twelve serotypes, including Enteritidis (21%) and Javiana (21%), were less likely to

29 f cross-immunizing infection with Salmonella Enteritidis; (3) an increase in the duration of infectio

30 of 85 Salmonella Typhimurium, 58 Salmonella Enteritidis, 32 other nontyphoidal Salmonella (NTS) sero

31 mologous (Typhimurium F98) and heterologous (Enteritidis 4973 and S. enterica O6,14,24: e,h-monophasi

32 proportion than Typhimurium (6%), including Enteritidis (7%), Heidelberg (13%), Choleraesuis (57%),

33 Enteritidis (80 to 100% vaccine efficacy).

34 m, followed by S. Heidelberg (10.86%) and S. Enteritidis (9.90%).

35 himurium SpvD having an arginine and serovar Enteritidis a glycine at this position.

36 ubsequent challenge with virulent Salmonella enteritidis a selection against lpf phase-on variants wa

37 l showing the highest binding affinity to S. enteritidis, a DNA sequence of high affinity to the bact

38 e phenotypic response to S. enterica serovar Enteritidis, an F1 population of chickens was created by

39 lates serotyped, 160 (45.6%) were Salmonella Enteritidis and 152 (43.3%) were Salmonella Typhimurium.

40 ng NTS isolates, >/=80% (79.7% of Salmonella Enteritidis and 90.2% of Salmonella Typhimurium isolates

41 sed to an inoculum of inactivated Salmonella Enteritidis and a chronic heat stress (CHS).

42 is of a patient with disseminated Salmonella enteritidis and a homozygous splice acceptor mutation in

43 mprises a positive selection step against S. enteritidis and a negative selection step against a mixt

44 reus) and Gram-negative microbes (Salmonella enteritidis and Escherichia coli O157:H7).

45 s aureus, Listeria monocytogenes, Salmonella enteritidis and Escherichia coli.

46 c areas that distinguished them from serovar Enteritidis and from each other.

47 Salmonella enterica serovars Enteritidis and Kentucky differ greatly in epidemiology.

48 54, fliH, fljB, csgB, spvR, and rfbMN) in S. Enteritidis and other Salmonella serovars.

49 ex vivo stimulation with Ags prepared from S Enteritidis and S Typhimurium.

50 from other Salmonella species, including S. enteritidis and S. choleraesuis.

51 er Salmonella enterica serovars including S. enteritidis and S. dublin can also kill C. elegans.

52 ng Dice similarities for S. enterica serovar Enteritidis and S. enterica serovar Typhimurium strains

53 enzyme combined PFGE for S. enterica serovar Enteritidis and S. enterica serovar Typhimurium strains,

54 ) for 74 strains each of S. enterica serovar Enteritidis and S. enterica serovar Typhimurium.

55 rs have the capacity to inhibit growth of S. enteritidis and S. typhimurium in bacterial cultures; th

56 amers, twelve rounds of selection to live S. enteritidis and S. typhimurium were performed, alternati

57 ection of highly specific DNA aptamers to S. enteritidis and S. typhimurium.

58 rain M5a1, Salmonella eastbourne, Salmonella enteritidis and Salmonella gelsenkirchen, respectively.

59 Salmonella Enteritidis and Salmonella Typhimurium are major causes

60 serovars of the Salmonella genus: Salmonella enteritidis and Salmonella typhimurium.

61 ing methods for Salmonella enterica serotype Enteritidis and survey the population structure of commo

62 H8 infected S. enterica serotypes Enteritidis and Typhimurium and Escherichia coli by init

63 Nontyphoidal Salmonella enterica serovars Enteritidis and Typhimurium are a common cause of gastro

64 Although S. enterica serovars Enteritidis and Typhimurium are responsible for most of

65 sm to evade cross-immunity between serotypes Enteritidis and Typhimurium.

66 Salmonella enterica serovar Enteritidis (S. enteritidis) and closely related serovars, suggesting th

67 Salmonella enterica serotype Enteritidis (S. enteritidis) and Escherichia coli O157:H7, has generated

68 m, 10% (10) were Salmonella enterica serovar Enteritidis, and 3% (3) were Salmonella enterica serovar

69 tions indicated that clinical isolates of S. enteritidis are highly heterogeneous in their ability to

70 Since S. Typhimurium and S. Enteritidis are the most common NTS serovars associated

71 of intracellular MRSA and 98% of Salmonella enteritidis at 2x the MIC.

72 a patient with Salmonella enterica serotype Enteritidis bacteremia.

73 s after inoculation with S. enterica serovar Enteritidis bacterin vaccine.

74 a collection of Salmonella enterica serotype Enteritidis bacteriophage.

75 med infection with the outbreak strains of S Enteritidis based on whole-genome sequencing (WGS), occu

76 dual strains of Salmonella enterica serotype Enteritidis beyond the phenotypic level; however, a cons

77 mbinant His-tagged flagellin from Salmonella enteritidis bound to TLR5 in detergent lysates from COS-

78 gainst S Typhi interacted with live intact S Enteritidis but did not bind intact S Typhimurium.

79 ears and case fatality was 20.3%; Salmonella Enteritidis case fatality (27.8%) was higher than for ot

80 Since 2010, Salmonella Enteritidis cases have risen and Salmonella Typhimurium

81 ella (NTS), mainly serotypes Typhimurium and Enteritidis, cause invasive infections with high mortali

82 Salmonella Enteritidis cells in a VBNC physiological state were eva

83 Enteritidis cells into mouse macrophages.

84 against heterologous S. Choleraesuis and S. Enteritidis challenge.

85 port the hypothesis that SPI-1 facilitates S Enteritidis colonization of the chicken and make SPI-1 a

86 Enteritidis compared to IgY from vaccinates, for both an

87 t IgY from multiple animals infected with S. Enteritidis compared to those infected with S. Hadar.

88 Enteritidis competes with commensal Enterobacteriaceae f

89 Stanleyville (91% vaccine efficacy), and S. Enteritidis CVD 1944 protected mice against the group D

90 The vaccines S. Typhimurium CVD 1931 and S. Enteritidis CVD 1944 were immunogenic and protected BALB

91 t international travel by linking Salmonella Enteritidis data from the National Antimicrobial Resista

92 Typhimurium and Salmonella enterica serovar Enteritidis DeltaguaBA DeltaclpX live oral vaccines to p

93 xtensive analysis of clinical isolates of S. enteritidis, demonstrate the complex nature of Salmonell

94 hly selective and can successfully detect S. enteritidis down to 600 CFU mL(-1) (equivalent to 18 CFU

95 Salmonella enterica subsp. enterica serovar Enteritidis, drugs that are not appropriate for therapy

96 ction against lpf phase ON cells of serotype Enteritidis during a subsequent challenge, suggesting th

97 Viable counts for serovar Enteritidis either matched the level of serovar Typhi (J

98 after an intravenous injection of Salmonella enteritidis endotoxin (10 mg/kg) or saline.

99 after an intravenous injection of Salmonella enteritidis endotoxin (10 mg/kg).

100 Administration of 0.5 mg/kg Salmonella enteritidis endotoxin to male Fischer rats induced a dra

101 nterference/cross-reactivity from Salmonella enteritidis, Enterobacter agglomerans, Pseudomonas putid

102 ofiles of Listeria monocytogenes, Salmonella enteritidis, Escherichia coli, during growth in the pres

103 gainst some food-borne pathogens (Salmonella enteritidis, Escherichia coli, Listeria monocytogenes an

104 e of related pathogens, including Salmonella enteritidis, Escherichia coli, Staphylococcus aureus, Ps

105 Clinical isolates of S. enterica serovar Enteritidis exhibit a wide spectrum of virulence in mice

106 ith native LT or with recombinant Salmonella enteritidis expressing LT-B.

107 A Tn10 insertion from a Salmonella enteritidis fimU mutant was transduced into S. typhimuri

108 ave analyzed the pathway by which Salmonella enteritidis flagellin (FliC) activates murine and human

109 surveillance of Salmonella enterica serovar Enteritidis for over 2 decades.

110 Enteritidis for oxygen, a resource critical for pathogen

111 cs of Salmonella BSI in Blantyre; Salmonella Enteritidis from 1999 to 2002, Salmonella Typhimurium fr

112 nome sequence analysis of 675 isolates of S. Enteritidis from 45 countries, we show the existence of

113 types of Salmonella may mitigate recovery of Enteritidis from chickens exposed by contact.

114 ntucky impacted the recovery of the pathogen Enteritidis from chickens.

115 of diversity within 104 isolates of serotype Enteritidis from eight unaffiliated poultry farms in Eng

116 on the molecular fingerprinting of serotype Enteritidis from poultry environments in the United King

117 tal of 192 NTS isolates (114 Typhimurium, 78 Enteritidis) from blood and stools from pediatric admiss

118 We estimate that S. enteritidis gastroenteritis developed in 224,000 persons

119 To investigate whether changes in serovar Enteritidis gene content contributed to this increased p

120 dentified in the Salmonella enterica serovar Enteritidis genome that is predicted to encode a protein

121 phism (SNP)-based cluster analysis of the S. Enteritidis genomes revealed well supported clades, with

122 Overall, almost all the serovar Enteritidis genomes were very similar to each other.

123 Overall, MLVA typing of Salmonella serotype Enteritidis had enhanced resolution, good reproducibilit

124 The infecting S. Enteritidis harbored a mutation in the mismatch repair g

125 Enteritidis-harboring mutations in functional homologs o

126 The infecting S. Enteritidis harboured a mutation in the mismatch repair

127 The incidence of Salmonella Enteritidis has been falling since 1997, and levels of S

128 The lipopolysaccharide (LPS) of Salmonella enteritidis has been implicated as a virulence factor of

129 symptomatic colonizers of chickens, serovars Enteritidis, Heidelberg, and Kentucky.

130 from the Gram-negative bacterium Salmonella Enteritidis, identifying AdrA as the most potent inducer

131 injected intramuscularly 2 weeks later with Enteritidis, (ii) hens were contact infected with Kentuc

132 contact infected with Kentucky and then with Enteritidis, (iii) hens were injected with Enteritidis o

133 Salmonella enterica serovar typhimurium and enteritidis in blood samples without culture enrichment.

134 Enteritidis in complex food matrix.

135 Furthermore, the growth rate of S. Enteritidis in culture was significantly inhibited by H-

136 a survival advantage to S. enterica serovar Enteritidis in eggs by repairing DNA damage caused by eg

137 genetic analysis identified two strains of S Enteritidis in human cases that were subsequently identi

138 ntial for efficient uptake or survival of S. enteritidis in macrophages.

139 , confers colonization resistance against S. Enteritidis in neonatal chicks, phenocopying germ-free m

140 environments, which may ultimately assist S. Enteritidis in persistent and silent colonization of chi

141 report on a technology to reduce Salmonella enteritidis in poultry.

142 try outbreak of Salmonella enterica serotype Enteritidis in the EU and European Economic Area (EEA).

143 uding two rare strains classified as serovar Enteritidis in the Salmonella reference collection B, on

144 ence that SEF14 fimbriae are expressed by S. enteritidis in vivo, previous studies showed that SEF14

145 The isolation rate of Salmonella serotype Enteritidis increased until 1996, whereas declines were

146 cted to evaluate whether NO production in S. Enteritidis-infected HD11 cells can be used as a biomark

147 Production of NO in S. Enteritidis-infected HD11 cells increased significantly

148 demonstrate that NO-based screening using S. Enteritidis-infected HD11 cells is a viable tool to iden

149 verse the suppression of NO production in S. Enteritidis-infected HD11 cells.

150 e highly discriminatory for IgY following S. Enteritidis infection (p < 0.05) compared to infections

151 implications for Salmonella enterica serovar Enteritidis infection and transmission to eggs, along wi

152 We defined an outbreak-associated case of S. enteritidis infection as one in which S. enteritidis was

153 an both prevent the spread of AMR Salmonella Enteritidis infection in chickens and shift the bacteria

154 ure of ice cream associated with cases of S. enteritidis infection were compared with those of produc

155 Enteritidis) infection covering 15 years in an interleuk

156 Enteritidis) infection covering 15 years in an interleuk

157 The incidence of S. enterica serovar Enteritidis infections has increased substantially in re

158 acid-resistant Salmonella enterica serotype Enteritidis infections in the United States and recent i

159 rease in the number of reports of Salmonella enteritidis infections.

160 ization after pathogenic S. enterica serovar Enteritidis inoculation and for circulating antibody lev

161 and transmission electron micrographs of S. enteritidis invasion of granulosa cells showed organisms

162 Salmonella enterica serovar Enteritidis is a common cause of foodborne illness in th

163 Salmonella enterica subsp. enterica serovar Enteritidis is a common food-borne pathogen, often assoc

164 S. Enteritidis is a further example of a Salmonella serotyp

165 Salmonella enterica serovar Enteritidis is a gram-negative bacterium that negatively

166 Salmonella enterica serovar Enteritidis is a major cause of food-borne diseases asso

167 Salmonella enterica serovar Enteritidis is a major cause of food-borne diseases in i

168 Salmonella enterica serovar Enteritidis is a major cause of foodborne disease in Uru

169 Salmonella enterica serovar Enteritidis is a significant cause of gastrointestinal i

170 Salmonella enterica serovar Enteritidis is an important food-borne pathogen, and chi

171 ogical characteristic of S. enterica serovar Enteritidis is its association with chicken shell eggs,

172 Salmonella enterica serovar Typhimurium, S. Enteritidis is known to have pathobiology specific to ch

173 S. Enteritidis is known to suppress nitric oxide (NO) produ

174 The structure of S. Enteritidis is more complex than previously known, as a

175 le each year and among pathogens, Salmonella Enteritidis is most widely found bacteria causing food b

176 y in recent decades, and S. enterica serovar Enteritidis is now one of the leading serovars of Salmon

177 Salmonella enterica serovar Enteritidis is often transmitted into the human food sup

178 Salmonella enterica serovar Enteritidis is one of the most prevalent Salmonella sero

179 Salmonella enterica serovar Enteritidis (S. Enteritidis) is a major etiologic agent of nontyphoid sa

180 Salmonella enterica serotype Enteritidis (S. enteritidis) is a major food-borne pathogen, and its inc

181 Salmonella enterica serovars Typhimurium and Enteritidis, is responsible for a major global burden of

182 type element with homology to the Salmonella enteritidis IS1351 element and Yersinia enterocolitica I

183 we conducted a retrospective analysis of S. Enteritidis isolates from seven epidemiologically confir

184 The resultant phylogeny allocated most S. Enteritidis isolates into two distinct clades (clades I

185 in the examined genomes grouped the serovar Enteritidis isolates into two major lineages.

186 al and animal origins of Salmonella serotype Enteritidis isolates may have a considerable influence o

187 f 65 arbitrary primers were screened with S. enteritidis isolates of different phage types.

188 With >89,400 bp surveyed across 98 S. Enteritidis isolates representing 14 distinct phage type

189 A total of 52 S. enterica serotype Enteritidis isolates representing 16 major outbreaks and

190 la Typhimurium and 30% (24/79) of Salmonella Enteritidis isolates tested were found to be multidrug r

191 characterized clinical and environmental S. Enteritidis isolates were sequenced.

192 s been developed to differentiate Salmonella enteritidis isolates.

193 able of detecting DNA polymorphisms among S. enteritidis isolates.

194 to be resistant to >/=1 agent for serotypes Enteritidis, Javiana, Panama, and Typhimurium.

195 d the effects of Salmonella enterica serovar Enteritidis lipopolysaccharide (LPS) and recombinant Sal

196 core polysaccharide-OPS (COPS) of Salmonella Enteritidis lipopolysaccharide (LPS) to flagellin protei

197 Escherichia coli, Salmonella enteritidis, Listeria innocua, Pseudomonas aeruginosa an

198 the published level of glucosylation for S. enteritidis LPS as well as for S. enteritidis LPS purcha

199 ion for S. enteritidis LPS as well as for S. enteritidis LPS purchased from Sigma Chemical Co., the 1

200 Enteritidis LPS were observed, and infants born with hig

201 N-gamma +/+ mice following injection with S. enteritidis LPS, despite sustaining 11-fold reductions i

202 ection with a hypotensive dose of Salmonella enteritidis LPS.

203 lowing injection of 300 microg of Salmonella enteritidis LPS.

204 kers for the response to S. enterica serovar Enteritidis may result in the enhancement of the immune

205 fferent hosts, including S. enterica serovar Enteritidis (multiple hosts), S. Gallinarum (birds), and

206 During a challenge with a serotype Enteritidis mutant carrying the lac promoter in front of

207 riae on colonization of mice with a serotype Enteritidis mutant in which the lpf promoter region was

208 f the 687 NTS isolates, including Salmonella Enteritidis (n = 244 [35.5%]), Salmonella Typhimurium (n

209 comprised serotypes Typhimurium (n = 43) and Enteritidis (n = 4).

210 0), Typhimurium (n = 163), Newport (n = 93), Enteritidis (n = 45), Dublin (n = 25), Pullorum (n = 9),

211 h Enteritidis, (iii) hens were injected with Enteritidis only, and (iv) hens were contact infected wi

212 ly, and (iv) hens were contact infected with Enteritidis only.

213 ontaminated with Salmonella enterica serovar Enteritidis or Salmonella enterica serovar Typhimurium a

214 ety of strains, which suggests that serotype Enteritidis organisms representing different genomic gro

215 a single culture-proven foodborne Salmonella enteritidis outbreak in 1994, Salmonella-induced gastroe

216 of commonly encountered S. enterica serotype Enteritidis outbreak isolates in the United States.

217 a single culture-proven foodborne Salmonella enteritidis outbreak that involved 1811 patients (mostly

218 erefore, more information is needed about S. Enteritidis pathobiology in comparison to that of S. Typ

219 S. Enteritidis persistently and silently colonizes the inte

220 monella enterica subspecies enterica serovar Enteritidis phage type (PT) 4, which peaked in 1993.

221 arge outbreak of Salmonella enterica serovar Enteritidis phage type 14b affecting more than 30 patien

222 ection B, only eleven regions of the serovar Enteritidis phage type 4 (PT4) chromosome (sequenced at

223 Eight isolates of S. enteritidis phage type 8 that failed to be discriminated

224 determine the relationships between some S. Enteritidis phage types (PTs) commonly associated with f

225 confer protection against challenge with S. enteritidis, presumably because lpf phase-off variants w

226 falling since 1997, and levels of Salmonella Enteritidis PT4 have fallen to preepidemic levels and ha

227 host-promiscuous Salmonella enterica serovar Enteritidis PT4 isolate P125109 and a chicken-restricted

228 roarray comparisons of the sequenced serovar Enteritidis PT4 to isolates of the closely related serov

229 Whereas CVD 1931 did not protect against S. Enteritidis R11, CVD 1944 did mediate protection against

230 wild-type strains S. Typhimurium I77 and S. Enteritidis R11, respectively, were constructed by delet

231 tected mice against lethal infection with S. Enteritidis R11.

232 10 exp9 CFU, and hens injected with serotype Enteritidis received 10 exp7 CFU intramuscularly.

233 sruption of this gene in S. enterica serovar Enteritidis rendered the organism more susceptible to eg

234 Salmonella Typhimurium and Salmonella Enteritidis represented 386 (49.2%) and 391 (49.9%), res

235 olonization with Salmonella enterica serovar Enteritidis requires a virulence-factor-dependent increa

236 U/mL and 94 CFU/mL for S. typhimurium and S. enteritidis, respectively, that could be attributed to t

237 lethal doses (LD50) of S. Typhimurium or S. Enteritidis, respectively.

238 ent blood-borne Salmonella enterica serotype Enteritidis (S.

239 re only found in Salmonella enterica serovar Enteritidis (S. enteritidis) and closely related serovar

240 hogens, such as Salmonella enterica serotype Enteritidis (S. enteritidis) and Escherichia coli O157:H

241 Salmonella enterica serovar Enteritidis (S. Enteritidis) is a major etiologic agent

242 Salmonella enterica serotype Enteritidis (S. enteritidis) is a major food-borne patho

243 ent protein from Salmonella enterica serovar Enteritidis, S. enterica serovar Typhimurium, and Pseudo

244 genes of Salmonella typhimurium, Salmonella enteritidis, Salmonella arizonae, Shigella sonnei, and S

245 O157:H7, Salmonella typhimurium, Salmonella enteritidis, Salmonella arizonae, Shigella sonnei, Shige

246 uginosa, Pseudomonas fluorescens, Salmonella Enteritidis, Salmonella Typhimurium, Escherichia coli).

247 Intestinal carriage of Salmonella Enteritidis (SE) in the chicken host serves as a reservo

248 onsin, reported Salmonella enterica serotype enteritidis (SE) infections during 1997 more than double

249 Salmonella enterica serovar Enteritidis (SE) is one of the most common food-borne pa

250 ess in humans annually in the United States; Enteritidis (SE) is the most common serotype.

251 N-susceptible isolate of S. enterica serovar Enteritidis (SE8743).

252 mbria genes were replaced both in Salmonella enteritidis (sefA, agfA and fimC) and Escherichia coli (

253 Enteritidis (SEn) by a single amino-acid residue, immuni

254 7.7%) from blood, 53 (30.8%) were Salmonella Enteritidis ST11 and 62 (36.0%) Salmonella Typhimurium S

255 human infection by some clades of Salmonella Enteritidis ST11 in East Africa, but not of human Salmon

256 identified cgMLST clusters within Salmonella Enteritidis ST11, Salmonella Heidelberg ST15, Salmonella

257 ctivity against Escherichia coli, Salmonella enteritidis, Staphylococcus aureus, and Mycobacterium bo

258 chicken macrophage HD11 cells, while dead S. Enteritidis stimulates a high level of NO production, su

259 osomal tlpA gene rendered a virulent serovar Enteritidis strain defective in intracellular survival a

260 for strain differentiation of more clonal S. Enteritidis strains and provides core genotypic markers

261 Enteritidis strains associated with or related to the U.

262 all this work shows that S. enterica serovar Enteritidis strains circulating in Uruguay have the same

263 -old and nineteen 10- to 20-year-old serovar Enteritidis strains from various hosts, using a Salmonel

264 ent or divergent in any of the other serovar Enteritidis strains tested.

265 ells compared to the serovar Typhimurium and Enteritidis strains tested.

266 Typhimurium and Salmonella enterica serovar Enteritidis strains that can serve as live oral vaccines

267 the subtyping of Salmonella enterica serovar Enteritidis strains to an epidemiologically relevant lev

268 Three divergent atypical Enteritidis strains were not virulent in BALB/c, but two

269 Chickens often carry S Enteritidis subclinically, obscuring the role of SPI-1 i

270 This RAPD approach to S. enteritidis subtyping provided more discriminatory power

271 allenge with nontyphoidal serovar Salmonella Enteritidis than with another nontyphoidal serovar, Salm

272 obal epidemic clade and two new clades of S. Enteritidis that are geographically restricted to distin

273 sed subtyping scheme for S. enterica serovar Enteritidis that relies on a single combined cluster ana

274 Enteritidis, the most common NTS serovar, accounted for

275 n a whole-gene scale were needed for serovar Enteritidis to become more prevalent in domestic fowl.

276 is able to reduce the ability of Salmonella Enteritidis to kill A459 respiratory cells.

277 ential for resistance of S. enterica serovar Enteritidis to nitrosative and oxidative stress.

278 e NTS serotypes also shifted from Salmonella Enteritidis to Salmonella Typhimurium.

279 To understand the mechanisms S. Enteritidis utilizes to colonize and persist in laying h

280 ntibody production after S. enterica serovar Enteritidis vaccination.

281 ggest that a bivalent (S. Typhimurium and S. Enteritidis) vaccine would provide broad protection agai

282 Enteritidis via Cell Systematic Evolution of Ligands by

283 e used transposon mutagenesis to identify S. Enteritidis virulence genes by assay of invasiveness in

284 -1beta secretion that contributes to serovar Enteritidis virulence.

285 S. enteritidis infection as one in which S. enteritidis was cultured from a person who became ill in

286 hicken ovarian granulosa cells by Salmonella enteritidis was examined in vitro.

287 S. enteritidis was found to attach specifically to fibronec

288 S. enteritidis was isolated from 8 of 226 ice cream product

289 an previously known, as a second clade of S. Enteritidis was revealed that is distinct from those com

290 Salmonella Enteritidis was the most frequent isolate, with 1944 of

291 e characteristics of clinical isolates of S. enteritidis, we determined the 50% lethal doses (LD(50))

292 he RNI/ROI resistance of S. enterica serovar Enteritidis, we transformed a genomic DNA library of SE2

293 Highly specific DNA aptamers to Salmonella enteritidis were selected via Cell-SELEX technique.

294 Salmonella enterica serovars Typhimurium and Enteritidis, were assessed using lipopolysaccharide (LPS

295 used to examine a panel of 29 isolates of S. enteritidis which had been previously characterized by o

296 serovar Typhimurium and S. enterica serovar Enteritidis, which are usually linked to localized gastr

297 I as most concordant for S. enterica serovar Enteritidis, while XbaI, BlnI, and SpeI were most concor

298 tified a gene, yafD from S. enterica serovar Enteritidis, whose overexpression conferred upon S. ente

299 iological association of S. enterica serovar Enteritidis with egg products.

300 ned as laboratory-confirmed infection with S Enteritidis with the multiple-locus variable-number tand